<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="3522" end="3525" sStart="3370" offset="152" sid="r8.way.n.0731" wn="1" wnkey="way%1:07:01::" text="If so, tryptophan concentrations in cellular microenvironments might play a critical role in modulating various cellular processes in a way that cannot be achieved by the hepatic enzyme TDO which regulates systemic tryptophan concentrations." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-2-5.anc" start="9906" end="9910" sStart="null" offset="0" sid="null" wn="1" wnkey="time%1:11:00::" text="Onset of expression coincided with the &lt;b&gt;time&lt;/b&gt; when the majority of cells had begun to adhere to the plate." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-2-5.anc" start="9906" end="9910" sStart="null" offset="0" sid="null" wn="7" wnkey="time%1:28:03::" text="Onset of expression coincided with the &lt;b&gt;time&lt;/b&gt; when the majority of cells had begun to adhere to the plate." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16883" end="16888" sStart="null" offset="14" sid="null" wn="3" wnkey="sense%1:09:02::" text="inches, while sense transfected controls had a mean of 0.69 sq." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="15221" end="15226" sStart="null" offset="18" sid="r9.sense.n.0981" wn="2147483646" wnkey="null" text="IDO-antisense and sense transfectants were aggregated in 1% DMSO and cell aggregates were visualized by phase contrast microscopy." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="40559" end="40564" sStart="null" offset="171" sid="r9.sense.n.0953" wn="2147483646" wnkey="null" text="This fragment was excised with Not I and subcloned into the Not I site of the mammalian expression vector pcDNA3 (Invitrogen), in either the sense or antisense orientation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="14293" end="14298" sStart="null" offset="120" sid="r9.sense.n.0153" wn="2147483646" wnkey="null" text="Clone C2, which expressed low levels of IDO antisense, depleted similar levels of tryptophan to the sense control." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16883" end="16888" sStart="null" offset="14" sid="null" wn="2147483644" wnkey="null" text="inches, while sense transfected controls had a mean of 0.69 sq." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16883" end="16888" sStart="null" offset="14" sid="null" wn="3" wnkey="sense%1:09:02::" text="inches, while sense transfected controls had a mean of 0.69 sq." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16418" end="16423" sStart="null" offset="64" sid="r9.sense.n.0983" wn="2147483646" wnkey="null" text="To quantitate and compare the size difference between sense and antisense-transfected aggregates we photographed sense and antisense clone 5 aggregates and calculated the area of each aggregate individually (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="19272" end="19277" sStart="null" offset="173" sid="r9.sense.n.0675" wn="3" wnkey="sense%1:09:02::" text="Expression of stromelysin s- 1 and 3 and meltrin ? , was increased in antisense-expressing aggregates, relative to the sense control (Fig 6A)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16883" end="16888" sStart="null" offset="14" sid="null" wn="3" wnkey="sense%1:09:02::" text="inches, while sense transfected controls had a mean of 0.69 sq." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="17724" end="17729" sStart="null" offset="117" sid="r9.sense.n.0388" wn="2147483644" wnkey="null" text="When inserts were coated with Matrigel, no significant migration was seen in either antisense or sense transfectants, indicating that cell motility could be inhibited by supplying an extracellular matrix." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16883" end="16888" sStart="null" offset="14" sid="r9.sense.n.0320" wn="2147483644" wnkey="null" text="inches, while sense transfected controls had a mean of 0.69 sq." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="13684" end="13689" sStart="null" offset="184" sid="r9.sense.n.0288" wn="2147483644" wnkey="null" text="Three antisense-transfected clones, which expressed progressively greater amounts of IDO antisense RNA were selected for further analysis together with a sense control (Fig 4D)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16883" end="16888" sStart="null" offset="14" sid="null" wn="3" wnkey="sense%1:09:02::" text="inches, while sense transfected controls had a mean of 0.69 sq." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="40188" end="40193" sStart="null" offset="34" sid="r9.sense.n.0170" wn="2" wnkey="sense%1:10:00::" text="Constructs which expressed either sense or antisense IDO RNA were produced by cloning a 740 bp RT-PCR fragment of the IDO gene, described in [ 17], into the T-tailed cloning vector pGEM T-Easy (Promega)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="26372" end="26376" sStart="null" offset="0" sid="null" wn="3" wnkey="rate%1:07:00::" text="Although some effect of indomethacin on cell growth &lt;b&gt;rate&lt;/b&gt; was observed, there was no sign of macroscopic foci (data not shown)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="26372" end="26376" sStart="null" offset="0" sid="null" wn="3" wnkey="rate%1:07:00::" text="Although some effect of indomethacin on cell growth &lt;b&gt;rate&lt;/b&gt; was observed, there was no sign of macroscopic foci (data not shown)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="26372" end="26376" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="Although some effect of indomethacin on cell growth &lt;b&gt;rate&lt;/b&gt; was observed, there was no sign of macroscopic foci (data not shown)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="26372" end="26376" sStart="null" offset="0" sid="null" wn="1" wnkey="rate%1:28:00::" text="Although some effect of indomethacin on cell growth &lt;b&gt;rate&lt;/b&gt; was observed, there was no sign of macroscopic foci (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="20883" end="20887" sStart="null" offset="232" sid="r7.poor.j.0179" wn="5" wnkey="poor%5:00:00:insufficient:00" text="Pharmacological inhibition of MMP activity in P19 cells using the broad spectrum, hydroxamic acid-based MMP inhibitor GM 6001 at concentrations ranging from 1-30 ?M, resulted in partial reversal of the poor aggregation shown by IDO-AS expressing cells, with a maximal effect shown at 20 ?M, indicating that changes in MMP expression were responsible, at least in part for altered cell adhesion." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="22627" end="22637" sStart="null" offset="3" sid="r10.particular.j.0315" wn="2147483647" wnkey="null" text="In particular, at a concentration of 2 mM, picolinic acid induced a more flattened phenotype." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="40968" end="40974" sStart="null" offset="152" sid="r9.normal.j.0761" wn="1" wnkey="normal%3:00:01::" text="Stable transfectants were selected in 400 mg/ml G418 over a period of 4 weeks and subsequently maintained in the absence of G418 in normal growth medium." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="36337" end="36343" sStart="null" offset="35" sid="r9.normal.j.0436" wn="1" wnkey="normal%3:00:01::" text="IDO regulates adhesion of cells to normal growth substrates." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="11279" end="11285" sStart="null" offset="42" sid="r9.normal.j.0734" wn="2" wnkey="normal%3:00:02::" text="Thus, removing cells from their normal growth substrate and reseeding into fresh medium induced a burst of IDO expression irrespective of whether cells reassociated with tissue culture substrate or other cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="34293" end="34299" sStart="null" offset="161" sid="r9.level.n.0313" wn="1" wnkey="level%1:07:00::" text="Treatment of IDO-expressing RAW clones with a known inducer of COX-2 (LPS), revealed a lack of correlation between COX-2 RNA and protein levels." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="25425" end="25431" sStart="null" offset="37" sid="r9.level.n.0559" wn="1" wnkey="level%1:07:00::" text="In contrast, COX-2 protein levels were higher in clones expressing lower amounts of IDO mRNA and lower in vector only controls, whereas COX-1 protein levels were unchanged by LPS treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="35017" end="35022" sStart="null" offset="116" sid="r9.level.n.0972" wn="2" wnkey="level%1:26:01::" text="Although not well understood, evidence for regulation of COX expression at the post-transcriptional level is increasing [ 44, 45]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="9556" end="9562" sStart="null" offset="48" sid="r9.level.n.0962" wn="1" wnkey="level%1:07:00::" text="Log phase cells do not express IDO at levels detectable by standard RT-PCR methods." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="31174" end="31180" sStart="null" offset="199" sid="r9.level.n.0794" wn="1" wnkey="level%1:07:00::" text="MC57 cells, which demonstrated similar changes in cell adhesion to RAW cells following IDO expression, exhibited lower levels of COX-2 synthesis upon IDO expression and lower levels of PG E 2 relative to other PGs such as D 2 . Furthermore, adding back PGE 2 to IDO-expressing MC57 cells did not reproduce the wild type phenotype (not shown)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="44906" end="44911" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The size of individual P19 aggregates was determined by capturing fields of 40-50 aggregates at 10x magnification and then calculating the area of each aggregate using the NIH &lt;b&gt;Image&lt;/b&gt; (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="7287" end="7291" sStart="null" offset="18" sid="r9.full.j.0767" wn="2" wnkey="full%5:00:01:whole:00" text="Transfection of a full length, constitutively expressed IDO cDNA into MC57 cells in the pcDNA3 expression vector, resulted in MC57 cells developing a more rounded phenotype." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="14572" end="14581" sStart="null" offset="65" sid="r8.1.different.j.0383" wn="1" wnkey="different%3:00:00::" text="IDO antisense-transfected clones D3 and E6 exhibited a different phenotype compared to untransfected and sense transfected P19 cells (Fig 5A,B,C)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="25079" end="25087" sStart="null" offset="62" sid="r10.control.n.0759" wn="4" wnkey="control%1:09:02::" text="Therefore, we treated IDO transfected RAW cells and controls with LPS and measured COX-2 expression 24 hours later." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="16203" end="16211" sStart="null" offset="272" sid="r10.control.n.0251" wn="2147483646" wnkey="null" text="5F) produced aggregates which were only loosely packed and a substantial number of cells which did not package into any form of aggregate while antisense clone D3 formed aggregates more diverse in shape than the uniformly spherical controls but less diverse than clone E6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="36194" end="36200" sStart="null" offset="37" sid="r10.common.j.0508" wn="3" wnkey="common%5:00:00:shared:00" text="Prostaglandins may provide a common link between these important biological phenomena." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="42102" end="42113" sStart="null" offset="81" sid="r11.combination.n.0310" wn="1" wnkey="combination%1:14:00::" text="COX-1 and COX-2 antibodies (Santa Cruz Biotechnology Inc) were used in combination with standard ECL techniques." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="12454" end="12462" sStart="null" offset="26" sid="r9.appear.v.0962" wn="1" wnkey="appear%2:39:00::" text="Therefore, IDO expression appeared to be induced by reattachment, rather than detachment from a previous substrate." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-5.anc" start="41457" end="41462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="An antisense primer was then &lt;b&gt;added&lt;/b&gt; and the cDNA PCR amplified for 25 cycles." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="40949" end="40956" sStart="null" offset="133" sid="null" wn="1" wnkey="absence%1:26:00::" text="Stable transfectants were selected in 400 mg/ml G418 over a period of 4 weeks and subsequently maintained in the absence of G418 in normal growth medium." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="40949" end="40956" sStart="null" offset="133" sid="r11.absence.n.0586" wn="1" wnkey="absence%1:26:00::" text="Stable transfectants were selected in 400 mg/ml G418 over a period of 4 weeks and subsequently maintained in the absence of G418 in normal growth medium." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="40949" end="40956" sStart="null" offset="133" sid="null" wn="1" wnkey="absence%1:26:00::" text="Stable transfectants were selected in 400 mg/ml G418 over a period of 4 weeks and subsequently maintained in the absence of G418 in normal growth medium." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="17259" end="17266" sStart="null" offset="175" sid="r11.absence.n.0971" wn="1" wnkey="absence%1:26:00::" text="P19 cells were seeded into porous tissue culture inserts placed in a 24 well tissue culture plate and cell migration to the lower chamber in the absence of any stimulus was determined." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="10783" end="10790" sStart="null" offset="251" sid="r11.absence.n.0128" wn="1" wnkey="absence%1:26:00::" text="Differentiation is dependent on an initial, 3-5 day incubation as multicellular aggregates in suspension culture, in the presence of drug, followed by a similar period growing as monolayer adherent cells in the absence of drug." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="40949" end="40956" sStart="null" offset="133" sid="null" wn="1" wnkey="absence%1:26:00::" text="Stable transfectants were selected in 400 mg/ml G418 over a period of 4 weeks and subsequently maintained in the absence of G418 in normal growth medium." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-5.anc" start="10908" end="10915" sStart="null" offset="108" sid="r11.absence.n.0339" wn="1" wnkey="absence%1:26:00::" text="Mature differentiated cells begin to appear during this subsequent growth period in the absence of drug." />
  </sentences>
</list>